Cite
HARVARD Citation
Fehlings, M. et al. (2021). Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. Lancet neurology. 20 (2), pp. 98-106. [Online].